Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Net Income towards Common Stockholders (2021 - 2023)

Updated

Nika Pharmaceuticals' Net Income towards Common Stockholders was -$10,143 in Q3 2023, compared with -$6,339 a year earlier.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Net Income towards Common Stockholders (2021 - 2023) Analysis & Trends

On a trailing twelve-month basis, Nika Pharmaceuticals' Net Income towards Common Stockholders was -$72,569 through Sep 30, 2023; for FY2022, it was -$3.18 million.

  • In earlier years, Net Income towards Common Stockholders was -$14,712 in FY2021.
  • Quarterly Net Income towards Common Stockholders has moved between -$3.16 million (Q2 2022) and $5,754 (Q1 2021) over five years.
  • Per Business Quant data, NIKA's Net Income towards Common Stockholders in the three quarters before Q3 2023 was -$27,806 (Q2 2023), -$19,570 (Q1 2023) and -$15,050 (Q4 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -10,143.00
Jun 30, 2023 -27,806.00
Mar 31, 2023 -19,570.00
Dec 31, 2022 -15,050.00
Sep 30, 2022 -6,339.00
Jun 30, 2022 -3.16 Mn
Mar 31, 2022 -6,316.00
Dec 31, 2021 -26,124.00
Sep 30, 2021 2,699.00
Jun 30, 2021 2,959.00
Mar 31, 2021 5,754.00
API Access

Nika Pharmaceuticals, Inc Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NIKA&period=max&api_key=YOUR_API_KEY